%0 Journal Article
%T [Clinical characteristics and genetic analysis of a child with Neutral lipid storage disease with myopathy].
%A Zhang Y
%A Guo F
%A Lu N
%A Tang M
%A Wang D
%J Zhonghua Yi Xue Yi Chuan Xue Za Zhi
%V 41
%N 7
%D 2024 Jul 10
%M 38946369
暂无%R 10.3760/cma.j.cn511374-20220523-00312
%X <B>OBJECTIVE: </B>To explore the clinical phenotype and genetic basis of a child with Neutral lipid storage disease with myopathy (NLSDM).<BR><B>METHODS: </B>A child who was admitted to the First Affiliated Hospital of Zhengzhou University in February 2021 for a history of elevated creatine kinase (CK) for over 2 months was selected as the study subject. Clinical and laboratory examinations were carried out, and the child was subjected to whole exome sequencing. Candidate variants were validated by Sanger sequencing of her family members.<BR><B>RESULTS: </B>The patient, a 9-year-old female, had exhibited weakness in the lower limbs, elevated CK level, and refractory cardiomyotrophy. Genetic testing revealed that she has harbored c.32C>G (p.S11W) and c.516C>G (p.N172K) compound heterozygous variants of the PNPLA2 gene, which were respectively inherited from her mother and father. Based on the guidelines from the American College of Medical Genetics and Genomics (ACMG), both variants were rated as likely pathogenic (PM1+PM2_Supporting+PP3+PP4).<BR><B>CONCLUSIONS: </B>The c.32C>G (p.S11W) and c.516C>G (p.N172K) compound heterozygous variants of the PNPLA2 gene probably underlay the myasthenia gravis and elevated creatine kinase in this child.